Combination of Temsirolimus and Bevacizumab in Patient With Metastatic Renal Cell Carcinoma

NCT00619268 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Renal Cell Carcinoma

Interventions

DRUG: Temsirolimus
DRUG: Bevacizumab
DRUG: Sunitinib
DRUG: Interferon alpha-2a

Sponsor

Centre Leon Berard